4//SEC Filing
Rasty Siyamak 4
Accession 0000899243-19-015642
CIK 0001661998other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:09 PM ET
Size
5.2 KB
Accession
0000899243-19-015642
Insider Transaction Report
Form 4
Rasty Siyamak
Chief Operating Officer
Transactions
- Sale
Common Stock
2019-06-03$20.22/sh−8,000$161,778→ 230,707 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $20.00 to $20.42. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001735450
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 6:09 PM ET
- Size
- 5.2 KB